Therapy Switches in Fingolimod-Treated Patients with Multiple Sclerosis: Long-Term Experience from the German MS Registry

INTRODUCTIONS: Therapy switches in patients with multiple sclerosis (MS) receiving treatment with fingolimod occur frequently in clinical practice but are not well represented in real-world data. The aim of this study was to identify and characterize treatment switches and reveal sociodemographic/cl...

Descripción completa

Detalles Bibliográficos
Autores principales: Frahm, Niklas, Fneish, Firas, Ellenberger, David, Flachenecker, Peter, Paul, Friedemann, Warnke, Clemens, Kleinschnitz, Christoph, Parciak, Tina, Krefting, Dagmar, Hellwig, Kerstin, Haas, Judith, Rommer, Paulus S., Stahmann, Alexander, Zettl, Uwe K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857375/
https://www.ncbi.nlm.nih.gov/pubmed/35020157
http://dx.doi.org/10.1007/s40120-021-00320-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8857375/
https://www.ncbi.nlm.nih.gov/pubmed/35020157
http://dx.doi.org/10.1007/s40120-021-00320-w

Ejemplares similares